Comment by thenaturalist

dbt Labs is a Series D company with hundreds of millions in funding and a 4.2 billion USD valuation at their last round.

Their CEO and founder spoke of an IPO in 2022.

Let's not pretend they are still remotely close to their humble beginnings or were able to get this far without credibly demonstrating they have a plan for how to make enterprises bleed through their nose for their product.

That's the future.

On the flipside, building a dbt adjacent product enhancing or complementing capabilities is basically a sure way of how to get bought.